The NASH patients showed higher TNF-α levels than the NAFL patients (p < 0.01) or the controls (p < 0.05) and lower BDNF plasma levels than the NAFL patients (p < 0.05). This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.